Compare ARK Genomic Revolution ETF (ARKG) vs InMode Ltd (INMD) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs InMode Ltd — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while InMode Ltd trades at $15.33 (market cap $878.88M). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, InMode Ltd nearer its low. Which is the better fit depends on your goals.
| ARKG | INMD | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $16.62 |
52-Week Low | $23.09 | $12.76 |
Market Cap | — | $878.88M |
Enterprise Value | — | $346.55M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
INMD trades at $15.28, up 1.8% on the day, with a bullish technical signal from moving averages and oscillators. The company reported a Q1 2026 earnings miss but maintains strong profitability with a 23.27% net income margin. Recent news includes an unsolicited acquisition proposal from Steel Partners at $16.75 per share, alongside ongoing securities fraud investigations announced in early July 2026.
The stock presents a mixed outlook; the acquisition offer and solid fundamentals suggest upside near the $16.50 consensus target, but legal scrutiny and earnings volatility pose significant risks. Investor sentiment is divided, with analysts evenly split between Buy and Hold ratings, reflecting uncertainty around the company's near-term trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About InMode Ltd
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →
